Published in N Engl J Med on September 23, 2004
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest (2008) 3.11
Rate of kidney function decline associates with mortality. J Am Soc Nephrol (2010) 2.76
Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest (2005) 2.75
Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation (2015) 2.58
For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Renal denervation in moderate to severe CKD. J Am Soc Nephrol (2012) 2.21
Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int (2009) 2.15
Macrophage roles following myocardial infarction. Int J Cardiol (2008) 2.14
Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis (2013) 2.04
Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis (2008) 1.82
Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes. Kidney Int (2014) 1.63
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol (2006) 1.59
Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol (2007) 1.57
Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv (2011) 1.57
The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol (2012) 1.55
Calibrating parametric subject-specific risk estimation. Biometrika (2010) 1.54
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ (2010) 1.50
Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study. Am J Kidney Dis (2011) 1.50
NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J Am Soc Nephrol (2010) 1.49
The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int (2006) 1.47
Transfusion practice in the intensive care unit: a 10-year analysis. Transfusion (2010) 1.46
Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease. J Hypertens (2011) 1.45
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins. Physiol Rep (2015) 1.40
Chronic kidney disease predicts cardiovascular disease. N Engl J Med (2004) 1.39
The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2006) 1.36
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study. Nephrol Dial Transplant (2006) 1.34
Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol (2010) 1.31
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol (2010) 1.26
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One (2010) 1.25
Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br J Gen Pract (2008) 1.23
Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol (2008) 1.22
Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol (2010) 1.22
Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis (2009) 1.21
Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol (2009) 1.19
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol (2008) 1.19
Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 1.16
Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med (2007) 1.15
Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004. Diabetes Care (2008) 1.14
Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol (2008) 1.12
Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol (2011) 1.09
In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a Registry of 8176 patients. Mayo Clin Proc (2010) 1.08
Early angiography in patients with chronic kidney disease: a collaborative systematic review. Clin J Am Soc Nephrol (2009) 1.07
The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest (2009) 1.06
The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions. J Card Fail (2015) 1.06
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods. BMC Nephrol (2014) 1.04
Predictors of heart failure in patients with stable coronary artery disease: a PEACE study. Circ Heart Fail (2009) 1.04
Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels (2011) 1.04
Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis (2008) 1.03
Impact of chronic kidney disease on the severity of initially diagnosed coronary artery disease and the patient prognosis in the Japanese population. Heart Vessels (2010) 1.02
More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care (2012) 1.00
Associations of dietary fat with albuminuria and kidney dysfunction. Am J Clin Nutr (2010) 0.99
Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol (2006) 0.98
P2Y12 platelet inhibition in clinical practice. J Thromb Thrombolysis (2012) 0.97
Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis. Int J Cardiovasc Imaging (2011) 0.97
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol (2009) 0.96
Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol. BMC Public Health (2010) 0.96
Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management. Int J Nephrol (2011) 0.96
Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens (2011) 0.95
Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol (2011) 0.95
Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant (2012) 0.94
Association of preventive health care with atherosclerotic heart disease and mortality in CKD. J Am Soc Nephrol (2009) 0.94
Renal dysfunction potentiates foam cell formation by repressing ABCA1. Arterioscler Thromb Vasc Biol (2009) 0.94
Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients. Korean Diabetes J (2010) 0.94
High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine. J Gen Intern Med (2008) 0.93
Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. J Am Heart Assoc (2015) 0.93
Recent trends in post-discharge mortality among patients with an initial acute myocardial infarction. Am J Cardiol (2012) 0.91
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy. World J Urol (2011) 0.91
Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol (2011) 0.90
Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol (2009) 0.90
Role of vitamin D in chronic kidney disease. Semin Nephrol (2009) 0.90
Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J (2011) 0.90
The impact of hypertension on patients with acute coronary syndromes. Int J Hypertens (2011) 0.90
Challenges of conducting a trial of uric-acid-lowering therapy in CKD. Nat Rev Nephrol (2011) 0.90
Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol (2008) 0.90
Relation between mild to moderate chronic kidney disease and coronary artery disease determined with coronary CT angiography. PLoS One (2012) 0.89
Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol (2006) 0.89
Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease. Int J Nephrol (2012) 0.89
Risks of death and end-stage renal disease after surgical compared with percutaneous coronary revascularization in elderly patients with chronic kidney disease. Circulation (2012) 0.88
Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling. BMC Syst Biol (2011) 0.88
Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma. Proteome Sci (2011) 0.88
Low ankle-brachial index and the development of rapid estimated GFR decline and CKD. Am J Kidney Dis (2012) 0.88
Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol (2011) 0.88
Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes. Kidney Int (2005) 0.88
Diabetes: treating diabetic nephropathy-still an unresolved issue. Nat Rev Endocrinol (2012) 0.88
Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal (2012) 0.88
Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD. Clin J Am Soc Nephrol (2015) 0.87
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. Am J Kidney Dis (2015) 0.87
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18
Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med (2010) 14.43
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr (2010) 13.12
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med (2005) 12.46
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Universal definition of myocardial infarction. Circulation (2007) 11.69
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
The ClinicalTrials.gov results database--update and key issues. N Engl J Med (2011) 9.83
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med (2012) 9.46
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Universal definition of myocardial infarction. Eur Heart J (2007) 9.04
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Universal definition of myocardial infarction. J Am Coll Cardiol (2007) 8.68
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet (2003) 8.12
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med (2012) 7.93
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. N Engl J Med (2007) 7.86
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Rosuvastatin in older patients with systolic heart failure. N Engl J Med (2007) 7.55
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med (2013) 7.35
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79